Missing Information
  • A System Error Has Occured:0177 - Failed to Load All Sections.
Company:  FLEXION THERAPEUTICS INC (FLXN)
Form Type:  SC 13G
Filing Date:  2/14/2018 
CIK:  0001419600 
Address:  10 MALL ROAD
SUITE 301
 
City, State, Zip:  BURLINGTON, Massachusetts 01803 
Telephone:  (781) 305-7777 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$19.53  
Change: 
0.54 (2.84%)  
Trade Time: 
Dec 06  
Market Cap: 
$745.55M
Trade FLXN now with

© 2019  
Description of Business
Unless the content requires otherwise, references to "Flexion," "Company," "we," "our," and "us," in this Annual Report refer to Flexion Therapeutics, Inc. and our subsidiary, Flexion Therapeutics Securities Corporation. Overview We are a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, a type of degenerative arthritis. We have an approved product, ZILRETTA®, which we market in the United States. ZILRETTA is the first and only extended-release, intra-articular, or IA (meaning in the joint), injection indicated for the management of OA knee pain. ZILRETTA is a non-opioid therapy that employs our proprietary microsphere technology to provide effective pain relief.